Cargando…
Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance
Combination chemotherapy in clinical practice has been generally accepted as a feasible strategy for overcoming multidrug resistance (MDR). Here, we designed and successfully prepared a co-delivery system named S-D1@L-D2 NPs, where denoted some smaller nanoparticles (NPs) carrying a drug doxorubicin...
Autores principales: | Zhang, DanDan, Kong, Yan Yan, Sun, Jia Hui, Huo, Shao Jie, Zhou, Min, Gui, Yi Ling, Mu, Xu, Chen, Huan, Yu, Shu Qin, Xu, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360411/ https://www.ncbi.nlm.nih.gov/pubmed/28356731 http://dx.doi.org/10.2147/IJN.S128790 |
Ejemplares similares
-
Intracellular targeted co-delivery of shMDR1 and gefitinib with chitosan nanoparticles for overcoming multidrug resistance
por: Yu, Xiwei, et al.
Publicado: (2015) -
Lipid–Saporin Nanoparticles for the Intracellular Delivery of Cytotoxic Protein to Overcome ABC Transporter-Mediated Multidrug Resistance In Vitro and In Vivo
por: Zhang, Guan-Nan, et al.
Publicado: (2020) -
Surfactin-based nanoparticles loaded with doxorubicin to overcome multidrug resistance in cancers
por: Huang, Wenjing, et al.
Publicado: (2018) -
Folate-mediated mitochondrial targeting with doxorubicin-polyrotaxane nanoparticles overcomes multidrug resistance
por: Wang, He, et al.
Publicado: (2014) -
Targeted multidrug delivery system to overcome chemoresistance in breast cancer
por: Tang, Yuan, et al.
Publicado: (2017)